Skip to content

Products and Substances

This page helps parents think clearly about the difference between a treatment, a product, and a substance or ingredient.

If your main question is "what kind of eczema treatment is this and when is it used?", start with Treatments and Solutions. This page is for thinking about exact products and what inside them may matter.

Why this distinction matters

Families often say:

  • "This cream helped"
  • "That ointment made it worse"
  • "My child reacts to this product"

Those statements may be true, but the real signal may sit at different levels:

  • the treatment type may be right or wrong
  • the exact product formulation may matter
  • one ingredient may explain benefit or irritation

Three useful levels

Treatment

A treatment is the broad solution type.

Examples:

  • topical steroid
  • moisturiser
  • bleach bath
  • wet wrap
  • tacrolimus
  • dupilumab

Product

A product is the exact item used.

Examples:

  • Vanicream Moisturizing Cream
  • CeraVe Moisturizing Cream
  • Aquaphor Healing Ointment
  • EpiCeram
  • a specific tacrolimus ointment brand
  • a specific hypochlorous acid spray

Substance or ingredient

A substance is the active ingredient or another notable material inside a product.

Examples:

  • petrolatum
  • ceramides
  • tacrolimus
  • pimecrolimus
  • crisaborole
  • roflumilast
  • ruxolitinib
  • tapinarof
  • sodium hypochlorite
  • hypochlorous acid
  • coconut oil
  • zinc oxide
  • fragrance

Product groups that matter most

Moisturisers and barrier products

Parents usually compare these by:

  • thickness
  • sting potential
  • fragrance-free status
  • how well the child tolerates them
  • whether the family will actually use them consistently

Brands available without a prescription in Greek and European pharmacies include Eucerin AtopiControl, Bioderma Atoderm, A-Derma Exomega Control, CeraVe, Cetaphil Restoraderm, Avène XeraCalm A.D., La Roche-Posay Lipikar, and Mustela Stelatopia. See Pharmacy Products — Emollients for a full comparison table with key substances per product.

Prescription topicals

This group includes:

  • steroid creams and ointments
  • tacrolimus or pimecrolimus products
  • newer nonsteroidal products

All prescription topicals require a prescription in Greece. European brand names include Protopic (tacrolimus), Elidel (pimecrolimus), Locoid (hydrocortisone butyrate), Advantan (methylprednisolone aceponate), and Elocon (mometasone furoate). Note that some substances widely described in US-centric sources — crisaborole (Eucrisa/Staquis), roflumilast cream (Zoryve), ruxolitinib cream for eczema (Opzelura), and tapinarof (VTAMA) — are not available in Europe as of April 2026. See Pharmacy Products — prescription topicals for full details.

For the practical "who is this for and how is it usually used?" view, see Treatments and Solutions.

Supportive and adjunct products

These may include:

  • bleach bath materials used in the right dilution
  • wet wrap materials
  • hypochlorous acid sprays
  • eczema-tolerated sunscreens

Home-remedy style products

These often need extra care:

  • black tea compresses
  • coconut oil
  • magnesium-rich bath salts
  • homemade mixtures

Ingredients that often deserve attention

Ingredients that may help

  • petrolatum — physically seals the barrier and reduces transepidermal water loss
  • ceramides (most effective in products with balanced lipid ratios: ceramides + cholesterol + free fatty acids at roughly equal proportions; ceramide-only products may not perform as well)
  • zinc oxide — protective, anti-inflammatory, and does not sting eyes
  • niacinamide — anti-inflammatory; found in several European pharmacy emollients
  • prescription active substances selected by a clinician

Prescription active substances: current and emerging

The number of active ingredients available for eczema is expanding. Current prescription substances and their European availability:

Substance EU/European availability EU brand name
Tacrolimus Available Protopic
Pimecrolimus Available Elidel
Dupilumab Available (EMA approved) Dupixent
Tralokinumab Available (EMA approved 2021) Adtralza
Lebrikizumab Available (EMA approved 2023) Ebglyss
Nemolizumab Available (EMA approved 2024) Nemluvio / Mitchga
Baricitinib Available (EMA approved from age 2) Olumiant
Upadacitinib Available (EMA approved) Rinvoq
Abrocitinib Available (EMA approved) Cibinqo
Crisaborole Not available — EMA authorisation withdrawn 2022
Roflumilast (topical) Not available — no EMA approval
Ruxolitinib (for eczema) Not available for eczema — EMA approved for vitiligo only Opzelura (vitiligo indication only)
Tapinarof Not available — no EMA approval

2026 pipeline substances (not yet approved anywhere): amlitelimab (anti-OX40L), tilrekimig (trispecific IL-4/IL-13/TSLP blocker), KT-621 (oral STAT6 degrader), rademikibart (anti-IL-4Rα), rezpegaldesleukin (T-regulatory cell therapy)

For what each of these is used for and when, see Treatments and Solutions. For specific product names and prescription information see Pharmacy Products.

Ingredients or product features that may cause trouble

  • Sodium lauryl sulphate (SLS): a surfactant found in aqueous cream and some other products that damages the skin barrier; aqueous cream should not be used as a leave-on emollient
  • fragrance and essential oils
  • harsh preservatives (especially methylisothiazolinone/methylchloroisothiazolinone)
  • alcohol-heavy formulations
  • complex "natural" blends with many botanical extracts

Sometimes the problem is not the treatment idea itself, but the formulation.

A more useful question: is the problem the product or the ingredient?

When something helps or harms, ask:

  • did the whole treatment type fit the situation
  • did this exact product have a texture or formula my child could not tolerate
  • was one ingredient likely to matter most

This is often more useful than simply collecting long lists of product names.

How to compare products more clearly

When a product seems to help or harm, it helps to ask:

  1. What treatment category was it part of?
  2. What exact product was used?
  3. What ingredients or substances are most likely to matter?
  4. Was anything else changed at the same time?
  5. What happened over the next 24 to 72 hours?

A practical example

Instead of writing:

New cream made things worse

it is much more useful to write:

New moisturiser: CeraVe Moisturizing Cream
Treatment type: moisturiser / barrier care
Notable substances: ceramides
Body areas: cheeks and behind knees
Change seen: stinging on cheeks within 10 minutes; no problem behind knees

That level of detail is what makes later pattern review possible.

A practical shortcut

Use this page when the question is:

  • which moisturiser or sunscreen should we compare
  • which ingredient might be stinging
  • whether a product reaction is about fragrance, preservatives, oils, or the active medicine

Use Treatments and Solutions when the question is:

  • should we ask about tacrolimus
  • what is tapinarof cream
  • when do bleach baths or wet wraps make sense
  • what options exist beyond steroid creams